Beth S. Rose

Beth S. Rose: Attorney with Sills Cummis & Gross P.C. AV stamp icon
Attorney Awards


Beth S. Rose is a Member of Sills Cummis & Gross, where she is Chair of the Product Liability Practice Group and a Co-Chair of the Litigation Practice Group. She has tried complex product liability cases to verdict in state and federal courts throughout the country. Ms. Rose is the lawyer to whom General Counsel turn when they need an aggressive but practical approach to “bet the company” product liability matters. Clients rely on her expertise to develop successful and cost-effective strategies consistent with their business goals.

Ms. Rose has over 25 years of experience successfully defending complex product liability matters for a variety of regulated products including pharmaceuticals, medical devices, consumer products, foods, chemicals (asbestos, silica and benzene) and construction/industrial machines. She also has experience defending product liability cases which arise from clinical trials and catastrophic workplace accidents. Her practice ranges from single plaintiff cases, to state coordinated proceedings, multi-district litigation and class actions. During her career, Ms. Rose has served as national counsel to several companies, including those in the pharmaceutical, medical device and contract research organization spaces, defending mass tort litigation. She has also served as New Jersey counsel to entities defending complex product liability claims in New Jersey’s Multi-County Litigation system.

Ms. Rose also serves as New Jersey counsel to generic pharmaceutical companies in Hatch-Waxman and related intellectual property litigation. She regularly appears in the U.S. District Court of New Jersey in such matters and is knowledgeable regarding the local patent rules established by the court.

Ms. Rose also has experience managing e-discovery in complex product liability and mass tort litigation for domestic and international companies. She conducts investigations and counsels clients on e-discovery issues as appropriate.

Ms. Rose is a member of DRI’s Drug and Medical Device Steering Committee. She is a Master and Board Member of the Morris Pashman Inn of Court in Bergen County. She serves on the Firm’s Management Committee and leads the Sills Women’s Initiative.

Ms. Rose’s experience has earned her recognition in numerous industry publications. She has been highly ranked in Chambers USA Guide to America’s Leading Lawyers for Business since 2008. The 2016 edition reported that Ms. Rose is “‘very knowledgeable and thorough,’ adding ‘She felt like a business partner to us when working through problems.’” She was selected for inclusion in the 2015 NJBIZ “Best 50 Women in Business” list, the 2014-2018 editions of Benchmark Litigation: America’s Leading Litigation Firms and Attorneys and in the 2014-2018 editions of Benchmark’s Top 250 Women in Litigation: The Definitive Guide to the Leading Female Attorneys in the US .

Press Releases

Benchmark Litigation 2019 Names Sills Cummis & Gross to the Top Tier of New Jersey Litigation Law Firms


Sills Cummis & Gross Named “New Jersey Firm of the Year” for the Second Consecutive Year by Benchmark Litigation


Benchmark Litigation 2018 Names Sills Cummis & Gross to the Top Tier of New Jersey Litigation Law Firms


Beth S. Rose Listed in 2017 Edition of Benchmark’s Top 250 Women in Litigation


Sills Cummis & Gross Recognized as New Jersey Litigation Firm of the Year: Second Honor in Past Three Months


Benchmark Litigation 2017 Names Sills Cummis & Gross to the Top Tier of New Jersey Litigation Law Firms


Beth S. Rose Named One of Benchmark’s Top 250 Women in Litigation in the U.S.


Benchmark Litigation 2016 Names Sills Cummis & Gross to the Top Tier of New Jersey Litigation Law Firms


Beth S. Rose Again Named One of Benchmark’s Top 250 Women in Litigation in the U.S.


Sills Cummis & Gross Member Beth S. Rose Named to the NJBIZ Best 50 Women in Business List for 2015


Benchmark Litigation 2015 Names Sills Cummis & Gross to the Top Tier of New Jersey Litigation Law Firms


Beth S. Rose Named One of Benchmark’s Top 250 Women in Litigation in the U.S.


Sills Cummis & Gross’ Commercial Litigation Department Named as the Finalist in New Jersey Law Journal’s “Litigation Department of the Year”


Sills Cummis & Gross Nominated for Benchmark Litigation’s Inaugural US Benchmark Annual Awards


In The News Items

Top Women in Law: Beth Rose

New Jersey Law Journal 11/5/2018

Law Journal Names Top Women in the Law 2018

New Jersey Law Journal 10/1/2018

Sills Celebrates in Civic-Minded Fashion: Firm Anniversary Brings Together Law, Business, Government and Policy

Metropolitan Corporate Counsel 1/3/2017

New Jersey Law Journal 2016 General Litigation Department of the Year Winner, Midsized Firm

New Jersey Law Journal 11/14/2016

Rainmaker Q&A: Sills Cummis' Beth Rose

Law360 8/23/2016

What Attorneys Wish They Knew When They Graduated

Law360 6/26/2015

And The Defense Wins

The Voice 7/24/2013

And The Defense Wins

The Voice 6/19/2013

Q&A With Sills Cummis' Beth Rose

Law360 4/3/2013

And The Defense Wins

The Voice 12/12/2012

NJ High Court Won't Disturb Novartis Bone Drug Win

Law360 11/7/2012

Pathways to Success

New Jersey Lawyer Magazine 4/1/2012

And the Defense Wins

The Voice 12/1/2010

Most Admired Attys: Sills Cummis' Beth Rose

Law360 9/8/2010

E-Discovery: Opt for Major Changes Rather than Tinkering at the Edges of the Rules

The Metropolitan Corporate Counsel 8/1/2010

The Costly Impact of E-Discovery

The Metropolitan Corporate Counsel 4/1/2010

Product Liability

New Jersey Business magazine (May 2009) 5/1/2009

DJ Tales of the Tape: Wyeth Faces Trials over Hormone Drugs

Dow Jones Newswires 8/17/2006

Vioxx Verdict Casts Pall Over Value of Merck Stock

The Star-Ledger 8/21/2005

Women and Minorities in the Legal Profession

New Jersey Law Journal 11/3/2003


Life Sciences Seminar

Preemption and Failure to Warn Claims in OTC Drug Cases: Perfect Together? 11/30/2017

2017 International Client Seminar

Product Recalls in the 21st Century: The Good, the Bad and the Ugly ALFA International 3/3/2017

Drug & Device Defense Forum

Be Prepared: Best Practices, Tips and Strategies for Trial Preparation HB Litigation Conferences 12/13/2016

Current Issues in Pharmaceutical, Medical Device, and Biotech Litigation

Navigating Relationships with Codefendants and Third Party Witnesses ABA Section of Litigation Pharmaceutical, Medical Device and Biotech Subcommittee of the Products Liability Committee 11/4/2016

2016 DRI Annual Meeting

Trolling for Cases in the Twenty-first Century: The Plaintiffs Bar Goes Digital DRI 10/21/2016

Defending Drug and Medical Device Litigation: A Primer for Young Lawyers

Defending the 30(b)(6) and Other Company Witness Depositions DRI’s Drug and Medical Device Committee 9/20/2016

Product Malfunction Theory

Medmarc 6/10/2016

Turning Up the Heat on Effective Litigation Strategies: The Hottest Topics in Product Liability and Complex Torts

Product Malfunction Theory: When “Smart” Products Act Dumb ALFA International - Product Liability & Complex Torts Practice Group 5/18/2016

Mass Torts Judicial Forum with Hon. Marina Corodemus (ret.)

Obtaining a Fair and Impartial Jury: Important Procedural Trends in Jury De-Selection HB Litigation Conferences 4/15/2016

Frivolous Litigation Sanctions in New Jersey State Court: Achieving Them & Avoiding Them

New Jersey Institute for Continuing Legal Education 1/15/2016

Trying the Product Liability Case: Tips and Strategies from the Pros

IADC (International Association of Defense Counsel) 1/13/2016

Litigation and Claims Trends for the Life Sciences Industry: The 2015 Year In Review and Forecast for 2016

Medmarc 12/16/2015

Ambulance Chasing in the 21st Century: The Plaintiffs' Bar Goes Digital

Berkley Life Sciences 11/18/2015

2015 Women of the Section of Litigation Conference: Leading, Litigation and Connecting

Trying a Products Liability Case: Best Practices, Tips and Strategies American Bar Association - The Women of the Section of Litigation 11/11/2015

2015 Intermediate Life Sciences Program

(1) Human Clinical Trials: Legal, Regulatory and Ethical Issues; and (2) Indemnification Issues 11/4/2015

Drug and Device Defense Forum

Getting The Word Out-Labeling & Promotion for Brands/Generics HB Litigation Conferences 10/20/2015

2015 DRI Annual Meeting

Lessons Learned from E-Discovery Sanctions in Mass Tort Litigation: Where Do We Go from Here DRI 10/8/2015

Preserving Products After Adverse Events: FDA Compliance and Products Liability Risk Management

Medmarc 8/27/2015

Developments Every In-House Counsel Needs to Know: Proposed Amendments to the Federal Rules of Civil Procedure, Class Action Developments, and Developments in E-Discovery and Sanctions

Sills Cummis & Gross 4/23/2015

Business Development Summit

Qualities of Rainmakers New Jersey Women Lawyers Association 2/24/2015

Experts in Life Sciences Litigation: Do’s, Don’ts, and other Practical Tips

Sills Cummis & Gross 10/7/2014

Advanced Life Science Specialist Forum: Loss and Litigation Trends

Sills Cummis & Gross 8/5/2014

Trial: A Multi-Chair Perspective

American Bar Association - Products Liability Committee 7/17/2014

DRI Product Liability Conference

Challenges Involving Foreign Entities as Defendants DRI 4/3/2013

Medmarc Insurance Company’s 25th Annual Medical Device Seminar

Drug and Medical Device Litigation: Navigating the Social Media Maze Medmarc Insurance Company 6/15/2012

Making the Most of Your Career

New York Women's Bar Association 4/10/2012

From Cradle to Grave: How Social Media Impacts Product Liability Litigation and Trial

How Social Media Has Impacted All Aspects of the Litigation Process ALFA International Product Liability Practice Group 9/21/2011

Defense Research Institute (DRI) Drug and Medical Device Seminar

Picking the Deepest Pocket: Defending a Case Where the Doctor Is at Fault but the Spotlight Is on Your Client Defense Research Institute 5/5/2011

E-Discovery, a Coast-to-Coast Update and Review

A panel discussion of Zubulake, Pension Committee and their impact upon practice and discovery beyond the Southern District of New York ALFA International 11/18/2010

The Top Ten Things Life Sciences Firms Need to Know about eDiscovery

Berkley Life Sciences 8/18/2010

E-Discovery Podcast

Berkley Life Sciences 8/10/2010

Pioneering Through the New Economic Frontier: Product Liability in a Changed World

Leveling the Playing Field: The Relationship Between U.S. and Foreign Manufacturers in Product Liability Litigation ALFA International Product Liability and International Law Practice Groups 3/13/2010

2009 ALFA International Health Care & Medical Device Joint Seminar

Legislative Developments in the Aftermath of Riegel and Levine ALFA International 6/4/2009

AFLA International's 2008 Product Liability Practice Group Seminar - Beyond the Horizon...A New Dawn for Global Product Liability Claims

Medical Device and Drug Product Liability Litigation, including Current Developments in Multi-District Litigation ALFA International 11/12/2008

Drug and Medical Device Litigation

Marcus Evans 10/25/2005

Minimizing Costs Associated with E-Discovery

Fios, Inc. 5/24/2005

Recent Developments in Preemption and E-Discovery

Life Sciences Seminar 4/7/2005

Drug and Medical Device Litigation Seminar: The Corporate Counsel Guide to Minimizing Risk and Reducing Exposure

Evolving Issues in the Wake of Baycol and Vioxx Marcus Evans 3/2/2005

E-Discovery Seminar

Minimizing Costs Associated with E-Discovery: Developing an Efficient but Comprehensive Approach Marcus Evans 11/11/2004

Women in Products Liability Seminar

Winning Litigation Strategies in the Age of the Vanishing Trial American Bar Association - Women in Products Liability Committee 11/9/2004

Advanced Life Sciences Seminar

Defeating Class Actions in Pharmaceutical and Medical Device Litigation, and Practical Tips for Evaluating Your Case 4/27/2004

Innovative Defense Strategies in Drug and Medical Device Litigation Conference

Successful Defense Strategies from High Profile and Often Highly Controversial Litigation: How to Apply these Tactics to Your Case Lexis/Nexis 3/22/2004

The Future of Class Action Litigation in America

Recent Developments in Class Certification American Bar Association 10/2/2003

Women in the Profession: Shattering the Glass Ceiling without Shattering Your Life

New Jersey Bar Association 6/26/2001

Fifth Annual Drug and Medical Device Litigation Seminar

Multi-District Litigation and Class Actions: A Multi Perspective Roundtable American Conference Institute 12/11/2000


Personal Jurisdiction in the Wake of ‘Bristol-Myers Squibb’

New Jersey Law Journal - Product Liability & Class Action Supplement 12/11/2017

Four Likely Implications from TC Heartland v. Kraft Foods

Metropolitan Corporate Counsel 7/1/2017

Authentication of Social Media Evidence: 2 Cases to Know

Law360 3/3/2017

When Personal Jurisdiction and Alter Ego Collide

Law360 2/16/2017

In Re Reglan Litigation: New Jersey Supreme Court Holds that Failure to Timely Update Claims Against Generic Drug Manufacturers Are Not Pre-Empted by Federal Law

International Association of Defense Counsel’s Drug, Device and Biotechnology Committee Newsletter 9/1/2016

Adverse Inferences for Spoliation of ESI: Do New Federal Rules Impact NJ Jurisprudence?

New Jersey Law Journal - Complex Litigation & E-Discovery Supplement 5/23/2016

Mobile Medical Apps and Product Liability (part two of a two-part article)

Product Liability Law & Strategy 4/1/2016

Mobile Medical Apps and Product Liability (part one of a two-part article)

Product Liability Law & Strategy 3/1/2016

Uncharted Territory: Mobile Medical Apps and Product Liability Collide

New Jersey Law Journal - Product Liability & Toxic Tort Supplement 12/14/2015

E-Discovery and Bring Your Own Devices to Work: The New Norm

DRI Annual Meeting Conference Handout 10/8/2015

Poking Holes in Pliva v. Mensing: Are Failure to Timely Update Label Claims Cognizable?

Metropolitan Corporate Counsel 1/1/2015

Service of Process and Personal Jurisdiction Defenses for Foreign Manufacturers: Navigating the Murky Waters of The Hague Service Convention and The Stream of Commerce Theory

DRI Product Liability Conference Handout 4/3/2013

Can Design-Defect Claims against Generic Pharma Survive? Pre-emption under Pliva v. Mensing

New Jersey Law Journal - Product Liability & Toxic Tort Supplement 12/17/2012

Computer-Assisted Review of E-Discovery: The First Order and Opinion Approving Its Use; Has the Future Arrived?

New Jersey Law Journal - Complex Litigation & E-Discovery Supplement 5/21/2012

Reducing the Impact of the Internet on Product-Liability Jury Trials

New Jersey Law Journal - Product Liability & Toxic Torts Supplement 12/12/2011

U.S. Supreme Court Reverses New Jersey’s Exercise of Personal Jurisdiction over Foreign Manufacturer

The Metropolitan Corporate Counsel 10/1/2011

Use of Social Networking Sites in Mass Tort Litigation: A Defense Perspective

New Jersey Lawyer Magazine 8/1/2011

The Who, What, When, Where and How of Litigation Holds

New Jersey Law Journal - Complex Litigation & E-Discovery Supplement 5/23/2011

Challenges for In-House Counsel in Multinational Corporations: Preserving the Attorney-Client Privilege in the Aftermath of Akzo Nobel Chemicals Ltd. v. European Commission

The Metropolitan Corporate Counsel 4/1/2011

Product Liability Actions and the Consumer Fraud Act: Living Together in Disharmony

New Jersey Law Journal - Product Liability & Toxic Torts Supplement 11/22/2010

A Cautionary Tale: The Duty to Preserve and Collect Documents Revisited

New Jersey Law Journal - Complex Litigation & E-Discovery Supplement 5/17/2010

Rule 1:38 and Presumption of Public Access to Records

Law360 - Product Liability Law 4/29/2010

Parallel Claims: Exact Contours Will Continue to Be Litigated

New Jersey Law Journal - Product Liability & Toxic Torts Supplement 12/14/2009

Effective Use of a Regulatory Expert in Product Liability Litigation

Metropolitan Corporate Counsel 11/1/2009

The Relationship between the Products Liability Act and the Consumer Fraud Act

New Jersey Law Journal - Product Liability & Toxic Torts Supplement 12/15/2008

The New Labeling Law: FDA's Authority to Regulate Label Changes and What It Means to the Pharmaceutical Industry

New Jersey Law Journal 12/17/2007

Preserving the Attorney Client Privilege in Corporate America

The Metropolitan Corporate Counsel 12/1/2006

Emerging Litigation Involving Human Research Subjects: A Future for Class Actions?

American Bar Association - The Brief 6/1/2006

Choosing New Jersey

New Jersey Law Journal 5/1/2006

Class Actions and Vioxx: Perfect Together?

New Jersey Law Journal 12/5/2005

Meeting E-Discovery Challenges

New Jersey Law Journal 9/12/2005

The Role of Class Actions in Litigation Involving Human Research Subjects

5 BNA Class Action Litigation Report 182 3/12/2004

Client Alerts

•In re Accutane Litigation: A Victory for Pharmaceutical Companies on Choice of Law and Label Warnings Product Liability 11/26/2018
•In re: Accutane Litigation: Is New Jersey a Daubert Jurisdiction? The New Jersey Supreme Court Adopts Daubert Factors But Stops Short of Declaring New Jersey a Daubert Jurisdiction Product Liability 10/17/2018
•Challenges Facing the Non-Settling Defendant: How to Present Evidence of a Settling Defendant's Liability Without Running Afoul of NJ's Evidentiary Rules Product Liability 8/1/2018
•Service of Process through Facebook as a Last Resort Product Liability 7/19/2017
•New Jersey Supreme Court Puts Out a Welcome Mat for Out-Of-State Plaintiffs with Time Barred Claims Product Liability 2/13/2017
•New Jersey Court Excludes “Made-For-Litigation” Causation Expert Opinions in Talc-Based Powder Products Litigation Product Liability 10/3/2016
•In Re Reglan Litigation: New Jersey Supreme Court Holds that Failure to Timely Update Claims against Generic Drug Manufacturers Are Not Pre-Empted by Federal Law Product Liability 8/24/2016
•Perdue v. Wyeth Pharmaceuticals, Inc.: A Triple Knockout on Pre-Emption and Innovator Liability Grounds Product Liability 8/3/2016
•The Duty Of Care in Take-Home Toxic-Tort Cases: Its Not Just for Spouses Anymore Product Liability 7/26/2016
•Dispositive Motions in Sheep’s Clothing: A Decision Every New Jersey Practitioner Needs to Know Product Liability 4/13/2016
•Spoliation and Adverse Inferences: Paper Documents Count Too! Product Liability 12/9/2015
•Raising the Bar for Design Defect Claims: A New Jersey Judge Puts Plaintiffs’ Feet to the Fire Product Liability 9/24/2015
•The New Jersey Supreme Court Puts Teeth Back into the “Net Opinion” Rule Product Liability 4/29/2015
•New Jersey Supreme Court Bars Ex Parte Judicial Communication with Jurors Product Liability 2/12/2015
•New Jersey Appellate Division Reverses Exercise of Personal Jurisdiction Over Foreign Manufacturer Product Liability 11/17/2014
•Documents Prepared by Hospitals and other Healthcare Facilities during the Investigation and Evaluation of an Adverse Event Are Privileged under New Jersey’s Patient Safety Act Product Liability 10/23/2014
•Parallel Claims Against Device Manufacturers post-Riegel Product Liability 8/4/2014
•In re Darvocet: Is There a “Parallel Misbranding” Exception to Generic Drug Preemption? Product Liability 8/1/2014
•Alabama Supreme Court: Brand-Name Pharmaceutical Manufacturer Can Be Sued for Injury Caused by Generic Product Product Liability 3/1/2013
•The Perils of Internet Research by Jurors Product Liability 4/1/2012
Kendall v. Hoffman-LaRoche, Inc. - The Interplay between the New Jersey Product Liability Act's Presumption of Adequacy for FDA-Approved Warnings and the Discovery Rule in Evaluating a Statue of Limitations Defense Product Liability 2/1/2012
•Product Liability Claims against Generics after Pliva v. Mensing: Do Any Claims Survive? Product Liability 1/1/2012
Bailey v. Wyeth, Inc. and DeBoard v. Wyeth, Inc. - New Jersey Product Liability Act’s Presumption that FDA-Approved Warnings Are Adequate Product Liability 10/1/2011
•U.S. Supreme Court Reverses New Jersey's Exercise of Personal Jurisdiction over Foreign Manufacturer Product Liability 8/1/2011
Pliva, Inc. v. Mesing - United States Supreme Court Holds That Failure to Warn Claims against Generic Pharmaceutical Manufactures Are Pre-Empted by Federal Law Product Liability 6/1/2011
•Jury Trials in New Jersey: The Impact of Modern Technology on Jury Requests to “Read-Back” Trial Testimony Product Liability 3/1/2011
•Caution: Discussions between Counsel and Client during a Deposition May Not Be Privileged Product Liability 2/1/2011

Rankings and Recognition

Award for Outstanding Advocacy from Medmarc 2015

Benchmark Litigation: America’s Leading Litigation Firms and Attorneys 2014-2019
Benchmark’s Top 250 Women in Litigation: The Definitive Guide to the Leading Female Litigation Attorneys in the US 2014-2018

The Best Lawyers in America 2005-2019, Product Liability Litigation - Defendants, Commercial Litigation, Electronic Discovery and Information Management Law, Mass Tort Litigation/Class Actions - Defendants, Personal Injury Litigation - Defendants
Chambers USA Guide to America’s Leading Lawyers for Business 2008-2018, New Jersey Litigation: Products Liability
Expert Guides: Guide to the Best of the Best USA 2014 and 2016, top 30 product liability practitioners in the U.S.
Expert Guides: Guide to the World’s Leading Women in Business Law 2013-2017, Product Liability
Law360’s “10 Most Admired Product Liability Attorneys” in the Nation 2010
LMG Life Sciences “Life Sciences Star” 2012-2018
Martindale-Hubbell AV rating
NJBIZ Best 50 Women in Business 2015

New Jersey Law Journal’s Top Women in the Law 2018
New Jersey Law Journal’s “One of the Outstanding Lawyers among Women and Minorities” 2003
New Jersey Law Journal’s “40 Under 40” 2002
New Jersey Super Lawyers 2005-2018, Class Action/Mass Torts: Defense; Personal Injury - Products: Defense
New Jersey Super Lawyers “The Top 50 Women Super Lawyers” 2009-2015
New Jersey Super Lawyers “Top 100 Super Lawyers” 2011
Who’s Who Legal: The International Who’s Who of Product Liability Defence Lawyers 2012-2018

Who’s Who Legal Life Sciences: Product Liability 2017-2018

Ms. Rose has been quoted on the front page of the Business Section of New Jersey’s The Star-Ledger regarding her approach to handling complex cases.

Litigation Counsel of America
Member,International Association of Defense Counsel

Community Affiliations

Board Member,Cerebral Palsy of North Jersey

Areas of Practice (3)

  • Product Liability
  • E-Discovery/Technology
  • Litigation

Education & Credentials

Contact Information:
(973) 643-5877  Phone
(973) 643-6500  Fax
University Attended:
Wesleyan University, B.A., with honors, 1984
Law School Attended:
Georgetown University law Center, J.D., 1987
Year of First Admission:
1992, U.S. District Court, Southern District of New York; 1992, U.S. District Court, Eastern District of New York; 1987, New Jersey; 1989, New York; 1987, U.S. District Court, District of New Jersey


Professional Affiliations

Member, DRI
- Member, Drug and Medical Device Steering Committee
Member, American Bar Association
- Member, Litigation Section/Class Action Committee
- Co-Chair, Mass Tort Subcommittee of the Class Action Committee (June 2000 - April 2005)
Member, New Jersey State Bar Association
- Member, Product Liability Section
Member, The Association of the Federal Bar of New Jersey
Member, Essex County Bar Association
- Chair, Product Liability Subcommittee (June 2000 - July 2002)
Morris Pashman Inn of Court
- Board Member (June 2004 - present)
- Master (September 2004 - present)
- Barrister (September 2002 - September 2004)
Member, International Association of Defense Counsel

Community Affiliations

Board Member, Cerebral Palsy of North Jersey

Birth Information:
Hackensack, New Jersey, October 4, 1962

Peer Reviews

Documents (17)

Documents by this lawyer on



Newark, New Jersey

Contact Beth S. Rose

Required Fields

Required Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.